90 related articles for article (PubMed ID: 22782169)
1. Failure of intravenous cidofovir for generalized verrucosis in a patient with severe combined immunodeficiency.
Potthoff A; Wieland U; Kreuter A
Arch Dermatol; 2012 May; 148(5):659-60. PubMed ID: 22782169
[No Abstract] [Full Text] [Related]
2. No apparent effect of cidofovir in epidermodysplasia verruciformis.
Preiser W; Kapur N; Snoeck R; Groves RW; Brink NS
J Clin Virol; 2000 Feb; 16(1):55-7. PubMed ID: 10680741
[TBL] [Abstract][Full Text] [Related]
3. New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir.
Darwich E; Darwich L; Cañadas MP; Klaustermeier J; Ercilla G; Alsina-Gibert M; Mascaró JM
J Am Acad Dermatol; 2011 Aug; 65(2):e43-e45. PubMed ID: 21763546
[No Abstract] [Full Text] [Related]
4. [Efficacy and safety of intravenous cidofovir in the treatment of giant molluscum contagiosum in an immunosuppressed patient].
Foissac M; Goehringer F; Ranaivo IM; May T; Cuny JF; Schmutz JL; Lekaditi M
Ann Dermatol Venereol; 2014 Oct; 141(10):620-2. PubMed ID: 25288067
[No Abstract] [Full Text] [Related]
5. [Cidofovir gel 1% for treating papillomavirus lesions in a patient with congenital immunodeficiency].
Muñoz RM; Prado E; Cisneros JM; Bautista FJ
Enferm Infecc Microbiol Clin; 2010 Mar; 28(3):209-10. PubMed ID: 19733939
[No Abstract] [Full Text] [Related]
6. [Topical cidofovir as a treatment for plantar warts].
Troncoso Mariño A; Cuiña González JR; Inaraja Bobo MT; Allegue Rodríguez F
Farm Hosp; 2010; 34(1):48-9. PubMed ID: 20144824
[No Abstract] [Full Text] [Related]
7. Novel method of intralesional cidofovir injection into laryngotracheal papillomata.
Sahota RS; Uddin FJ; Al-Shukri J; Moir AA
J Laryngol Otol; 2011 Apr; 125(4):402-4. PubMed ID: 21281536
[TBL] [Abstract][Full Text] [Related]
8. Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection.
Kottke MD; Parker SR
J Am Acad Dermatol; 2006 Sep; 55(3):533-6. PubMed ID: 16908370
[TBL] [Abstract][Full Text] [Related]
9. Intravenous cidofovir treatment for recalcitrant warts in the setting of a patient with myelodysplastic syndrome.
Gröne D; Treudler R; de Villiers EM; Husak R; Orfanos CE; Zouboulis ChC
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):202-5. PubMed ID: 16441633
[TBL] [Abstract][Full Text] [Related]
10. Substantial effect of topical cidofovir 1% on recalcitrant warts in a renal-transplanted adolescent: a case report.
Kralund HH; Broesby-Olsen S; Bistrup C; Lorentzen HF
Transplantation; 2011 Apr; 91(7):e52-4. PubMed ID: 21436652
[No Abstract] [Full Text] [Related]
11. Topical cidofovir for molluscum contagiosum in children.
Zabawski EJ; Cockerell CJ
Pediatr Dermatol; 1999; 16(5):414-5. PubMed ID: 10627225
[No Abstract] [Full Text] [Related]
12. Topical cidofovir for viral warts in children.
Fernández-Morano T; del Boz J; González-Carrascosa M; Tortajada B; de Troya M
J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1487-9. PubMed ID: 21261749
[No Abstract] [Full Text] [Related]
13. Intralesional cidofovir for the treatment of a plantar wart.
Moore E; Kovarik C
J Am Acad Dermatol; 2015 Jul; 73(1):e23-4. PubMed ID: 26089066
[No Abstract] [Full Text] [Related]
14. Intracavitary cidofovir for human herpes virus-8-associated primary effusion lymphoma in an HIV-negative patient.
Stingaciu S; Ticchioni M; Sudaka I; Haudebourg J; Mounier N
Clin Adv Hematol Oncol; 2010 May; 8(5):367-74. PubMed ID: 20551896
[No Abstract] [Full Text] [Related]
15. Efficacy of intravenous cidofovir in the treatment of giant molluscum contagiosum in a patient with human immunodeficiency virus.
Erickson C; Driscoll M; Gaspari A
Arch Dermatol; 2011 Jun; 147(6):652-4. PubMed ID: 21339417
[No Abstract] [Full Text] [Related]
16. Intravenous cidofovir for recalcitrant verruca vulgaris in the setting of HIV.
Hivnor C; Shepard JW; Shapiro MS; Vittorio CC
Arch Dermatol; 2004 Jan; 140(1):13-4. PubMed ID: 14732654
[No Abstract] [Full Text] [Related]
17. Successful treatment with plasma exchange for disseminated cidofovir-resistant adenovirus disease in a pediatric SCT recipient.
Nishikawa T; Nakashima K; Fukano R; Okamura J; Inagaki J
Bone Marrow Transplant; 2012 Aug; 47(8):1138-9. PubMed ID: 22080967
[No Abstract] [Full Text] [Related]
18. The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients.
Wu SW; Chang HR; Lian JD
Nephrol Dial Transplant; 2009 Mar; 24(3):1034-8. PubMed ID: 19059933
[TBL] [Abstract][Full Text] [Related]
19. Should intralesional cidofovir be used for recurrent respiratory papillomatosis?
Donne A; Rothera M; Homer J
Clin Otolaryngol; 2010 Feb; 35(1):60. PubMed ID: 20447168
[No Abstract] [Full Text] [Related]
20. Epidermodysplasia verruciformis in a patient with HIV infection: no response to highly active antiretroviral therapy.
Carré D; Dompmartin A; Verdon R; Comoz F; Le Brun E; Freymuth F; Leroy D
Int J Dermatol; 2003 Apr; 42(4):296-300. PubMed ID: 12694498
[No Abstract] [Full Text] [Related]
[Next] [New Search]
